{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T07:07:16Z","timestamp":1648710436491},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.gastrohep.2018.05.028","type":"journal-article","created":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T20:25:59Z","timestamp":1530563159000},"page":"387-388","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Paciente con enfermedad de Crohn en tratamiento con adalimumab y esteroides que desarrolla aspergilosis pulmonar"],"prefix":"10.1016","volume":"42","author":[{"given":"Isabel","family":"Ferrer Bradley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Maroto Arce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Mora Escrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaqu\u00edn","family":"Hinojosa del Val","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2018.05.028_bib0030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"Rahier","year":"2014","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2018.05.028_bib0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.riam.2009.01.001","article-title":"Opportunistic co-infection in a patient with Crohn's disease during infliximab (anti-TNFalpha) therapy [Article in Spanish]","volume":"26","author":"Salavert","year":"2009","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.gastrohep.2018.05.028_bib0040","doi-asserted-by":"crossref","first-page":"316","DOI":"10.17235\/reed.2017.4564\/2016","article-title":"Invasive pulmonary aspergilosis in an immunocompromised patient with severe ulcerative colitis","volume":"109","author":"Marti Aguado","year":"2017","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.gastrohep.2018.05.028_bib0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: Clinical practice guidelines of the Infectious Disease Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gastrohep.2018.05.028_bib0050","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/MIB.0b013e3182a827d2","article-title":"Opportunistic infections due to inflammatory bowel disease therapy","volume":"20","author":"Dave","year":"2014","journal-title":"Inflamm Bowel Dis"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570518301596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570518301596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T20:11:05Z","timestamp":1559333465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570518301596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0210570518301596"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2018.05.028","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paciente con enfermedad de Crohn en tratamiento con adalimumab y esteroides que desarrolla aspergilosis pulmonar","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2018.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}